These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35667479)

  • 1. Pregnancy anxiety, placental corticotropin-releasing hormone and length of gestation.
    Ramos IF; Ross KM; Rinne GR; Somers JA; Mancuso RA; Hobel CJ; Coussons-Read M; Dunkel Schetter C
    Biol Psychol; 2022 Jul; 172():108376. PubMed ID: 35667479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy.
    Wadhwa PD; Porto M; Garite TJ; Chicz-DeMet A; Sandman CA
    Am J Obstet Gynecol; 1998 Oct; 179(4):1079-85. PubMed ID: 9790402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy anxiety predicts shorter gestation in Latina and non-Latina white women: The role of placental corticotrophin-releasing hormone.
    Ramos IF; Guardino CM; Mansolf M; Glynn LM; Sandman CA; Hobel CJ; Dunkel Schetter C
    Psychoneuroendocrinology; 2019 Jan; 99():166-173. PubMed ID: 30245329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental corticotrophin-releasing hormone trajectories in pregnancy: Associations with postpartum depressive symptoms.
    Almeida IF; Rinne GR; Coussons-Read M; Dunkel Schetter C
    Psychoneuroendocrinology; 2024 Jun; 164():107030. PubMed ID: 38537413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of corticotropin-releasing hormone during early pregnancy are associated with precocious maturation of the human fetus.
    Class QA; Buss C; Davis EP; Gierczak M; Pattillo C; Chicz-DeMet A; Sandman CA
    Dev Neurosci; 2008; 30(6):419-26. PubMed ID: 19127063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery.
    Hobel CJ; Dunkel-Schetter C; Roesch SC; Castro LC; Arora CP
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 3):S257-63. PubMed ID: 9914629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal phthalate exposure in relation to placental corticotropin releasing hormone (pCRH) in the CANDLE cohort.
    Barrett ES; Corsetti M; Day D; Thurston SW; Loftus CT; Karr CJ; Kannan K; LeWinn KZ; Smith AK; Smith R; Tylavsky FA; Bush NR; Sathyanarayana S
    Environ Int; 2022 Feb; 160():107078. PubMed ID: 35007898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal polycyclic aromatic hydrocarbon (PAH) exposure in relation to placental corticotropin releasing hormone (pCRH) in the CANDLE pregnancy cohort.
    Barrett ES; Workman T; Hazlehurst MF; Kauderer S; Loftus C; Kannan K; Robinson M; Smith AK; Smith R; Zhao Q; LeWinn KZ; Sathyanarayana S; Bush NR
    Front Endocrinol (Lausanne); 2022; 13():1011689. PubMed ID: 36440232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal exposure to childhood traumatic events, but not multi-domain psychosocial stressors, predict placental corticotrophin releasing hormone across pregnancy.
    Steine IM; LeWinn KZ; Lisha N; Tylavsky F; Smith R; Bowman M; Sathyanarayana S; Karr CJ; Smith AK; Kobor M; Bush NR
    Soc Sci Med; 2020 Dec; 266():113461. PubMed ID: 33126094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-specific associations between placental corticotropin releasing hormone and problem behaviors in childhood.
    Barrett ES; Sullivan A; Workman T; Zhang Y; Loftus CT; Szpiro AA; Paquette A; MacDonald JW; Coccia M; Smith R; Bowman M; Smith A; Derefinko K; Nguyen RHN; Zhao Q; Sathyanarayana S; Karr C; LeWinn KZ; Bush NR
    Psychoneuroendocrinology; 2024 May; 163():106994. PubMed ID: 38387218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation.
    Wadhwa PD; Garite TJ; Porto M; Glynn L; Chicz-DeMet A; Dunkel-Schetter C; Sandman CA
    Am J Obstet Gynecol; 2004 Oct; 191(4):1063-9. PubMed ID: 15507922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increases in maternal depressive symptoms during pregnancy and infant cortisol reactivity: Mediation by placental corticotropin-releasing hormone.
    Rinne GR; Somers JA; Ramos IF; Ross KM; Coussons-Read M; Dunkel Schetter C
    Dev Psychopathol; 2023 Oct; 35(4):1997-2010. PubMed ID: 35983792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy.
    Marinoni E; Korebrits C; Di Iorio R; Cosmi EV; Challis JR
    Am J Obstet Gynecol; 1998 Apr; 178(4):770-8. PubMed ID: 9579442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the association between placental corticotrophin-releasing hormone and postpartum depressive symptoms.
    Glynn LM; Sandman CA
    Psychosom Med; 2014 Jun; 76(5):355-62. PubMed ID: 24915294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotrophin-releasing factor immunostaining is present in placenta and fetal membranes from the first trimester onwards and is not affected by labour or administration of mifepristone.
    Cooper ES; Brooks AN; Miller MR; Greer IA
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):677-83. PubMed ID: 7828359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Placental Corticotropin-Releasing Hormone Inform Timing of Antenatal Corticosteroid Administration?
    Swales DA; Grande LA; Wing DA; Edelmann M; Glynn LM; Sandman C; Smith R; Bowman M; Davis EP
    J Clin Endocrinol Metab; 2019 Feb; 104(2):443-450. PubMed ID: 30215731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of postpartum depressive symptoms with elevated corticotropin-releasing hormone in human pregnancy.
    Yim IS; Glynn LM; Dunkel-Schetter C; Hobel CJ; Chicz-DeMet A; Sandman CA
    Arch Gen Psychiatry; 2009 Feb; 66(2):162-9. PubMed ID: 19188538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotrophin releasing hormone levels in human plasma and amniotic fluid during gestation.
    Emanuel RL; Robinson BG; Seely EW; Graves SW; Kohane I; Saltzman D; Barbieri R; Majzoub JA
    Clin Endocrinol (Oxf); 1994 Feb; 40(2):257-62. PubMed ID: 8137526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and alpha-fetoprotein concentrations.
    McLean M; Bisits A; Davies J; Walters W; Hackshaw A; De Voss K; Smith R
    Am J Obstet Gynecol; 1999 Jul; 181(1):207-15. PubMed ID: 10411821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal exposure to placental corticotropin-releasing hormone is associated with child self-reported internalizing symptoms.
    Howland MA; Sandman CA; Glynn LM; Crippen C; Davis EP
    Psychoneuroendocrinology; 2016 May; 67():10-7. PubMed ID: 26855003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.